These memory CD8+ T cell responses are more easily triggered than naïve CD8+ T cells and were shown to eliminate host hepatocytes that were successfully transduced by rAAV vectors (141), resulting in reduced or absent transgene expression in clinical trials of rAAV gene therapies for muscle and liver-related genetic diseases (143, 145, 146). This evidence concerns the gene CD8A and hereditary disease.